Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
60.8M
-
Number of holders
-
108
-
Total 13F shares, excl. options
-
20.5M
-
Shares change
-
-290K
-
Total reported value, excl. options
-
$1.97B
-
Value change
-
+$10M
-
Put/Call ratio
-
1.27
-
Number of buys
-
55
-
Number of sells
-
-68
-
Price
-
$96.07
Significant Holders of ARGENX SE - ADR (ARGX) as of Q4 2018
140 filings reported holding ARGX - ARGENX SE - ADR as of Q4 2018.
ARGENX SE - ADR (ARGX) has 108 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.5M shares
of 60.8M outstanding shares and own 33.73% of the company stock.
Largest 10 shareholders include FMR LLC (3.49M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.1M shares), BAKER BROS. ADVISORS LP (1.02M shares), Redmile Group, LLC (961K shares), FEDERATED INVESTORS INC /PA/ (940K shares), BB BIOTECH AG (885K shares), venBio Select Advisor LLC (860K shares), EcoR1 Capital, LLC (825K shares), ORBIMED ADVISORS LLC (648K shares), and PERCEPTIVE ADVISORS LLC (561K shares).
This table shows the top 108 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.